• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.52% Nasdaq Down 0.25%

    AcelRx Pharmaceuticals, Inc. (ACRX)

    -NasdaqGM
    4.05 Down 0.07(1.70%) 4:00PM EDT
    |After Hours : 4.11 Up 0.06 (1.48%) 6:35PM EDT
    Add to Portfolio
    Prev Close:4.12
    Open:4.12
    Bid:4.11 x 2700
    Ask:4.54 x 1500
    1y Target Est:5.50
    Beta:3.31
    Next Earnings Date: 3-Aug-15ACRX Earnings announcement
    Day's Range:4.01 - 4.19
    52wk Range:2.96 - 9.32
    Volume:356,357
    Avg Vol (3m):636,084
    Market Cap:179.56M
    P/E (ttm):N/A
    EPS (ttm):-0.99
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACRX

    Comparison

    Symbol% ChgMkt Cap
    ACRXDown 1.70%179.56M
    BAXDown 1.42%21.47B
    HSPUp 0.09%15.47B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):34.44
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.74
    Quarterly EPS Est (Jun-15) :-0.26
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain. The company’s lead product candidate is Zalviso, an investigational, pre-programmed, non-invasive, handhe... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback